「fo」の検索結果
126件：31～35件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
http://www.senju.co.jp/english/about/message.html -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
al of Ophthalmology. 2026;283:163-175. 外部リンク Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
https://www.senju.co.jp/rd/thesis/ -
发表论文 | 研究与开发 | 千寿制药株式会社
almology. 2026;283:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
http://www.senju.co.jp/chinese/rd/thesis/ -
千寿製薬株式会社
新闻 2025年12月22日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel ...
https://www.senju.co.jp/chinese/ -
Presence of Products | Overseas Activities | SENJU Pharmaceutical
d in JP About Senju Lists About Senju CEO Message Management Policy Company Profile Our Initiatives for Society / Environment Business Activities Research Laboratories Production
https://www.senju.co.jp/english/global/world.html